
See exactly how ELIL's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ELIL and 80,000+ other tickers.
The Direxion Daily LLY Bull 2X ETF is engineered to deliver daily investment results that are twice (200%) the performance of Eli Lilly and Company's (LLY) common shares. Conversely, the Direxion Daily LLY Bear 1X ETF endeavors to provide daily returns equal to the inverse (opposite) of LLY's share performance, at a 100% ratio. Both ETFs pursue these objectives before factoring in any fees or operational expenses.

2025 has so far been a big year for leveraged ETFs. I wrote a research note on leveraged ETFs earlier this year (read more here) where I discussed some trends in the leveraged ETF market.

Getting stuck in sideways purgatory can leave traders flummoxed. Should they cut bait or ride out the position in hopes that it will eventually trend upwards?

Wall Street delivered mixed-to-downbeat performance last week thanks to Powell's warning of stagflation, rise of auto stocks on policy hopes, NVIDIA's $5.5B hit on export curb and upbeat retail sales.